From USD 5.7 billion in 2019, the global eClinical solutions market is predicted to grow to USD 13.4 billion by 2025, registering a CAGR of 14.0% during the forecast period (2020–2025). The market has witnessed huge demand for electronic data capture, and clinical data management system over the last few years, owing to the increasing demand for improved data standardization. Different types of solutions such as electronic data capture (EDC) and clinical data management system (CDMS), clinical trial management system (CTMS), clinical analytics platforms, and randomization and trial supply management are majorly contributing to the global eClinical solutions market size.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market/request-sample

Owing to the growing geriatric population and mounting occurrence of chronic diseases has resulted in increased frequency of pipeline drugs, which further increases the number of clinical trials for the introduction of novel drugs. Other factors driving the growth of the global eClinical solutions market are the amplified IT budgets for drug development and modification from manual data analysis to real-time data analysis. Apart from this, increasing integration of software solutions in clinical trials is expected to provide a boost to the market. Currently due to increasing trend of outsourcing clinical trials to contract based labs/organization’s and is poised to aid the market gain in the coming times. Due to, growing number of research programs in European & Asian countries like China, India, Japan, Taiwan and development of cost-effective modules are anticipated for incremental demand for such solutions.

Some of the major factors hampering the growth of the global eClinical solutions market are the high cost of implementation, the low adoption rate of the software, lack of high-speed broadband facility and long approval time. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.

Asia-Pacific market is predicted to witness fastest growth in the global eClinical solutions market during the forecast period (2020–2025). The major factors driving the growth of the market in the APAC region are huge population base, easy patient recruitment, and the existence of less strict regulatory standards. Additionally, growing government sponsoring to strengthen clinical trials, the less operational cost for clinical trials, increasing healthcare expenditure, increasing outsourcing of clinical trials, and growing number of pharmaceutical companies and CROs are also boosting the growth of the Asia-Pacific eClinical solutions industry.

Read More: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market

Key market players in the global eClinical solutions industry are investing capital to develop technologically advanced systems. In February 2018, OmniComm Systems, Inc. acquired Algorics, to enhance its product portfolio in a clinical analytics solution.

The major players in the global eClinical solutions market are Oracle Corporation, PAREXEL International Corporation Medidata Solutions, Inc., DATATRAK International, Inc., eClinical Solutions, Inc., Bio-Optronics, Inc., ERT, MaxisIT Inc., and OmniComm Systems, Inc.

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: [email protected]

Website: www.vynzresearch.com